Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case–control study, United Kingdom, 2022

BACKGROUND: Understanding the relative vaccine effectiveness (rVE) of new COVID-19 vaccine formulations against SARS-CoV-2 infection is a public health priority. A precise analysis of the rVE of monovalent and bivalent boosters given during the 2022 spring-summer and autumn-winter campaigns, respect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzilena, Anastasia, Hyams, Catherine, Challen, Rob, Marlow, Robin, King, Jade, Adegbite, David, Kinney, Jane, Clout, Madeleine, Maskell, Nick, Oliver, Jennifer, Finn, Adam, Danon, Leon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690860/
https://www.ncbi.nlm.nih.gov/pubmed/38037728
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.48.2300173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690860/
https://www.ncbi.nlm.nih.gov/pubmed/38037728
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.48.2300173

Ejemplares similares